Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering Global Pharma President Cox To Tackle Flagging Allergy Sales

Executive Summary

The first priority for Schering-Plough's new Global Pharmaceutical President Carrie Cox will be implementing marketing changes for the company's allergy franchise

You may also be interested in...



Schering Says Smaller Is Better: Flexibility Aids Turnaround Process

Schering-Plough's smaller size will be an advantage as the company implements its turnaround plan, CEO Fred Hassan told investors during a business briefing in New York Nov. 18

Schering Says Smaller Is Better: Flexibility Aids Turnaround Process

Schering-Plough's smaller size will be an advantage as the company implements its turnaround plan, CEO Fred Hassan told investors during a business briefing in New York Nov. 18

Schering Stabilizes Market Share Losses With Revamped Sales Effort

Schering-Plough's efficacy-based sales and marketing messages have helped stabilize share losses within the company's primary care business, Global Pharmaceutical President Carrie Cox said

Related Content

UsernamePublicRestriction

Register

PS041827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel